Evaluation of anthithrombin III therapeutic effect by frequency of administration in sepsis-associated disseminated intravascular coagulatio
Not Applicable
- Conditions
- Sepsis-associated disseminated intravascular coagulation
- Registration Number
- JPRN-UMIN000018074
- Lead Sponsor
- Gifu University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Age: under 20 years old Hematopoietic malignancy such as lykemia Patient under the anticoagulan treatment such as heparin or warfarin Liver cirrhosis (Child-Pugh score C) The patient will die within a few days regardless of treatment.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The period of improving DIC.
- Secondary Outcome Measures
Name Time Method Improvment of coagurative and inflammatory marker